Clinical trial · Interventional
Assessment of Substitution of Focused Cliches and Ultrasound for Tomosynthesis
NCT01612650CI-TRIAL-00032211TOMOSEINcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to assess if using tomosynthesis for breast cancer surveillance will allow a significant decrease of ultrasound cliches (and radiation exposure)
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| 2D Mammography | — | UNRESOLVED | — |
| 3D Mammography | — | UNRESOLVED | — |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 2D mammography | Device | — | UNRESOLVED |
| tomosynthesis | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- breast cancer histologically proven
- description
- Patient with breast cancer histologically proven, addressed to Oscar Lambret Center for treatment
- interventionNames
- Device: tomosynthesis
- Device: 2D mammography
- type
- ACTIVE_COMPARATOR
- label
- surveillance of a treated breast cancer
- description
- surveillance of patient already treated for breast cancer must have annual mammography
- interventionNames
- Device: tomosynthesis
- Device: 2D mammography
- type
- ACTIVE_COMPARATOR
- label
- diagnosis of a detected anomaly
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * woman with breast cancer histologically proven (group 1), on surveillance of a treated breast cancer (group 2) or diagnosis of an detected anomaly * age ≥ 40 years (group 1, group 2); age ≥ 50 years (group 3) * breast size suitable for detector size * possible prior mastectomy * security social covered * signed informed consent Exclusion Criteria: * breast implant * high genetic risk (mutation) * under justice measures * breast feeding or pregnant woman
References
Publications (0)
Data not yet available
No reference posted for this study.